喘中的新生物标志物
Nikita Agrawal1, Monica Kraft1,2
1Division of Pulmonary Critical Care and Sleep Medicine, Department of Medicine.
Current opinion in pulmonary medicine
|February 14, 2025
概括
识别新的生物标志物对于理解复杂的呼吸道疾病喘至关重要. 目前的生物标志物,如埃索诺菲尔不够,需要对个性化喘治疗的新指标进行进一步研究.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 免疫学 免疫学 免疫学
- 生物标志物发现发现
背景情况:
- 喘是一种普遍存在的全球呼吸道疾病,以气道炎症为标志.
- 它代表了一个具有复杂,重叠的生物机制的异质性疾病.
- 了解这些机制是开发有效喘治疗的关键.
研究的目的:
- 审查当前生物标志物在喘管理中的应用.
- 探索新生物标志物的未来潜力,以了解喘.
- 突出现有生物标志物在预测治疗反应方面的局限性.
主要方法:
- 关于喘生物标志物的最近研究的文献综述.
- 来自各种来源的生物标志物的分析:唾液,血液,尿液和呼出的呼吸.
- 检查乙酸性炎症,巨细胞的参与,和俱乐部细胞分泌蛋白质.
主要成果:
- 喘中的生物标志物研究正在进化,超出了全氨基酸细胞计数的范围.
- 新的研究重点是对乙氨基基细胞活性,亚种群和介质的研究.
- 新兴研究探讨了丸细胞参与和丸细胞分泌蛋白在喘表型.
结论:
- 由于喘的复杂性,在某个时间点依靠单个生物标志物是不够的.
- 进一步的研究对于识别和验证喘的适当生物标志物至关重要.
- 需要新的生物标志物来改善喘患者个性化治疗策略.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
231
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
231
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management
339
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
339
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
41
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
41


